Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EPS (Basic): 2015-2024

Historic EPS (Basic) for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$5.12.

  • Anaptysbio's EPS (Basic) rose 147.37% to $0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.74, marking a year-over-year increase of 54.93%. This contributed to the annual value of -$5.12 for FY2024, which is 15.79% up from last year.
  • Anaptysbio's EPS (Basic) amounted to -$5.12 in FY2024, which was up 15.79% from -$6.08 recorded in FY2023.
  • Anaptysbio's 5-year EPS (Basic) high stood at -$0.73 for FY2020, and its period low was -$6.08 during FY2023.
  • Its 3-year average for EPS (Basic) is -$5.26, with a median of -$5.12 in 2024.
  • As far as peak fluctuations go, Anaptysbio's EPS (Basic) skyrocketed by 79.72% in 2020, and later crashed by 189.04% in 2021.
  • Over the past 5 years, Anaptysbio's EPS (Basic) (Yearly) stood at -$0.73 in 2020, then slumped by 189.04% to -$2.11 in 2021, then tumbled by 116.59% to -$4.57 in 2022, then slumped by 33.04% to -$6.08 in 2023, then rose by 15.79% to -$5.12 in 2024.